This week’s Research Ethics Roundup highlights the research implications of the Drug Enforcement Administration (DEA) decision to keep marijuana a Schedule 1 drug, public concern about hackers and stored genetic information, one bioethics professor’s take on the National Institutes of Health’s proposed policy for funding chimera research, and the European Medicines Agency’s response to a French clinical trial that left one man dead. Read more